Drug and device product liability litigation strategy:
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Oxford [u.a.]
Oxford Univ. Press
2012
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"-- Provided by publisher. Includes bibliographical references and index |
Beschreibung: | XI, 524 S. 24 cm |
ISBN: | 9780199734948 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV040628339 | ||
003 | DE-604 | ||
005 | 20130118 | ||
007 | t | ||
008 | 121212s2012 xxu |||| 00||| eng d | ||
010 | |a 2011024678 | ||
020 | |a 9780199734948 |c pbk. |9 978-0-19-973494-8 | ||
035 | |a (OCoLC)826548367 | ||
035 | |a (DE-599)BVBBV040628339 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-29 | ||
050 | 0 | |a KF8925.P7 | |
082 | 0 | |a 346.7303/8 | |
100 | 1 | |a Herrmann, Mark Leonhard |e Verfasser |0 (DE-588)170752550 |4 aut | |
245 | 1 | 0 | |a Drug and device product liability litigation strategy |c Mark Herrmann, David B. Alden |
264 | 1 | |a Oxford [u.a.] |b Oxford Univ. Press |c 2012 | |
300 | |a XI, 524 S. |c 24 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"-- Provided by publisher. | ||
500 | |a Includes bibliographical references and index | ||
650 | 4 | |a Products liability |x Medical instruments and apparatus |z United States |x Trial practice | |
650 | 4 | |a Products liability |x Drugs |z United States |x Trial practice | |
650 | 7 | |a LAW / General |2 bisacsh | |
650 | 7 | |a LAW / Litigation |2 bisacsh | |
650 | 7 | |a LAW / Medical Law & Legislation |2 bisacsh | |
651 | 4 | |a USA | |
700 | 1 | |a Alden, David B. |e Verfasser |4 aut | |
856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025455665&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-025455665 |
Datensatz im Suchindex
_version_ | 1804149738134568960 |
---|---|
adam_text | DRUG AND DEVICE PRODUCT LIABILITY LITIGATION STRATEGY
/ HERRMANN, MARK
: 2011
TABLE OF CONTENTS / INHALTSVERZEICHNIS
ACKNOWLEDGMENTS
1. INTRODUCTION
2. THE FDA S REGULATION OF PRESCRIPTION DRUGS AND DEVICES
3. PRE-LITIGATION COUNSELING
4. LEGAL ISSUES & THEORIES
5. CONSOLIDATED PROCEEDINGS
6. AGGREGATED PROCEEDINGS - CLASS ACTIONS
7. AGGREGATED PROCEEDINGS - MULTIDISTRICT LITIGATION
8. FACT DISCOVERY
9. EXPERT RETENTION AND DISCOVERY
10. EXPERT TESTIMONY, RULE 702, AND DAUBERT
11. PREEMPTION
12. THE LEARNED INTERMEDIARY DOCTRINE
13. MOTIONS IN LIMINE
14. JURY SELECTION
15. THE TRIAL OF A DRUG OR DEVICE CASE
TABLE OF AUTHORITIES
INDEX.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
any_adam_object | 1 |
author | Herrmann, Mark Leonhard Alden, David B. |
author_GND | (DE-588)170752550 |
author_facet | Herrmann, Mark Leonhard Alden, David B. |
author_role | aut aut |
author_sort | Herrmann, Mark Leonhard |
author_variant | m l h ml mlh d b a db dba |
building | Verbundindex |
bvnumber | BV040628339 |
callnumber-first | K - Law |
callnumber-label | KF8925 |
callnumber-raw | KF8925.P7 |
callnumber-search | KF8925.P7 |
callnumber-sort | KF 48925 P7 |
callnumber-subject | KF - United States |
ctrlnum | (OCoLC)826548367 (DE-599)BVBBV040628339 |
dewey-full | 346.7303/8 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 346 - Private law |
dewey-raw | 346.7303/8 |
dewey-search | 346.7303/8 |
dewey-sort | 3346.7303 18 |
dewey-tens | 340 - Law |
discipline | Rechtswissenschaft |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02869nam a2200421zc 4500</leader><controlfield tag="001">BV040628339</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130118 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">121212s2012 xxu |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2011024678</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199734948</subfield><subfield code="c">pbk.</subfield><subfield code="9">978-0-19-973494-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)826548367</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040628339</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">KF8925.P7</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">346.7303/8</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Herrmann, Mark Leonhard</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)170752550</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug and device product liability litigation strategy</subfield><subfield code="c">Mark Herrmann, David B. Alden</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a.]</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 524 S.</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"-- Provided by publisher.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Products liability</subfield><subfield code="x">Medical instruments and apparatus</subfield><subfield code="z">United States</subfield><subfield code="x">Trial practice</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Products liability</subfield><subfield code="x">Drugs</subfield><subfield code="z">United States</subfield><subfield code="x">Trial practice</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Litigation</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Medical Law & Legislation</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alden, David B.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025455665&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025455665</subfield></datafield></record></collection> |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV040628339 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T00:27:48Z |
institution | BVB |
isbn | 9780199734948 |
language | English |
lccn | 2011024678 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025455665 |
oclc_num | 826548367 |
open_access_boolean | |
owner | DE-29 |
owner_facet | DE-29 |
physical | XI, 524 S. 24 cm |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Oxford Univ. Press |
record_format | marc |
spelling | Herrmann, Mark Leonhard Verfasser (DE-588)170752550 aut Drug and device product liability litigation strategy Mark Herrmann, David B. Alden Oxford [u.a.] Oxford Univ. Press 2012 XI, 524 S. 24 cm txt rdacontent n rdamedia nc rdacarrier "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"-- Provided by publisher. Includes bibliographical references and index Products liability Medical instruments and apparatus United States Trial practice Products liability Drugs United States Trial practice LAW / General bisacsh LAW / Litigation bisacsh LAW / Medical Law & Legislation bisacsh USA Alden, David B. Verfasser aut LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025455665&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Herrmann, Mark Leonhard Alden, David B. Drug and device product liability litigation strategy Products liability Medical instruments and apparatus United States Trial practice Products liability Drugs United States Trial practice LAW / General bisacsh LAW / Litigation bisacsh LAW / Medical Law & Legislation bisacsh |
title | Drug and device product liability litigation strategy |
title_auth | Drug and device product liability litigation strategy |
title_exact_search | Drug and device product liability litigation strategy |
title_full | Drug and device product liability litigation strategy Mark Herrmann, David B. Alden |
title_fullStr | Drug and device product liability litigation strategy Mark Herrmann, David B. Alden |
title_full_unstemmed | Drug and device product liability litigation strategy Mark Herrmann, David B. Alden |
title_short | Drug and device product liability litigation strategy |
title_sort | drug and device product liability litigation strategy |
topic | Products liability Medical instruments and apparatus United States Trial practice Products liability Drugs United States Trial practice LAW / General bisacsh LAW / Litigation bisacsh LAW / Medical Law & Legislation bisacsh |
topic_facet | Products liability Medical instruments and apparatus United States Trial practice Products liability Drugs United States Trial practice LAW / General LAW / Litigation LAW / Medical Law & Legislation USA |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025455665&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT herrmannmarkleonhard druganddeviceproductliabilitylitigationstrategy AT aldendavidb druganddeviceproductliabilitylitigationstrategy |